Since all these pathways are downstream of Ang II/AT1R signaling transduction (44), therapeutic strategies targeting molecules associated with Ang II signal transduction are promising to treat cardiac fibrosis and prevent HF. This evidence concerns the gene AGTR1 and hydrops fetalis.